Our proprietary ability to commercially produce IgY antibodies presents the breakthrough potential to solve some of the most important immune health challenges faced today.

Corporate Overview

IGY Life Sciences & Technology Inc. is a privately held Biotechnology Company specializing in the extraction, development and commercialization of broad spectrum antibodies, or immunoglobulin (IgY), for use as OTC nutraceutical and for development of specific vaccines. The company was formed in 2009 to commercialize a superior proprietary process for extraction of avian immunoglobulin from chicken egg yolks. IgY is a natural antibody for which there is an existing global demand.